EARLY AND SUSTAINED REMISSION AFTER TREATMENT WITH SC ADMINISTERED GOLIMUMAB IS ASSOCIATED WITH NORMALIZED HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS: POSTHOC-ANALYSIS FROM PURSUIT INDUCTION AND MAIN

(1) Universitätsklinik für Innere Medizin IV

(2) Department of Hepatogastroenterology and Centre d’Investigation Clinique

(3) Robarts Research Institute

(4) Janssen R&D, LLC.

(5) Janssen Global Services, LLC.

(6) Alfred Hospital

(7) Oregon Health Sciences University

(8) Orebro University Hospital

(9) University Hospital Gasthuisberg

(10) University of California San Diego



This item was part of the IBD III session at UEG Week 2013

This item can be cited as: United European Gastroenterology Journal; 2013: 1 (Supplement 1) A527

Categorisation:

  • Clinical Specialty
    • 'IBD-ology'
  • Diagnosis and Management
    • Medical management
  • Disease
    • Inflammatory bowel disease
  • Format
    • Abstract
  • Language
    • English
  • Year
    • 2013